Russia Travel Vaccine Market to 2032
Overview
The Russia Travel Vaccine Market is expected to reach a 328.09 USD Million by 2032 and is projected to grow at a CAGR of 11.28% from 2025 to 2032.
Revenue, 2024 (USD Million)
167.12
Forecast, 2032 (USD Million)
328.09
CAGR, 2024 - 2032
11.28%
Report Coverage
Russia
Russia Travel Vaccine Market 2018-2032 USD Million
Russia Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 167.12 USD Million
- Projected Market Size (2032): 328.09 USD Million
- CAGR (2025-2032): 11.28%
Key Findings of Russia Travel Vaccine Market
- The Russia Travel Vaccine Market was valued at 328.09 USD Million in 2024.
- The Russia Travel Vaccine Market is likely to grow at a CAGR of 11.28% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 136.50 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 19.57% during the forecast period from 2024 to 2032.
Russia Travel Vaccine Market Scope
Russia Travel Vaccine Market Segmentation & Scope
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Composition
- Mono Vaccines
- Combination Vaccines
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Russia Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 167.12 USD Million |
| Market Value in 2032 | 328.09 USD Million |
| CAGR (2025-2032) | 11.28% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Category,Type,Disease,Composition,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): Russia, leading in terms of revenue 167.12 USD Million in 2024
- Key Country: Russia, leading in terms of revenue with value of 167.12 USD Million in 2024.
Segments and Scope
-
Russia Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 77.55 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.70 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 46.62 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 12.42 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 26.50 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 19.57 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 114.49 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.44 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 129.09 USD Million in the year 2024.
- B2B is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.44 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 82.68 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.75 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 75.18 USD Million in the year 2024.
- Adult is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.93 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 87.31 USD Million in the year 2024.
- Male is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.50 % in forecast period 2025-2032.
-
Russia Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Russia Travel Vaccine Market to 2032 with a revenue of 136.50 USD Million in the year 2024.
- Injectable is the Fastest growing segment in Russia Travel Vaccine Market to 2032 with a Growth rate of 11.43 % in forecast period 2025-2032.
Russia Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Russia Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
Russia Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Russia Travel Vaccine Market is segmented based on Segmentation Category,Type,Disease,Composition,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration.
Russia Travel Vaccine Market was valued at USD 167.12(Revenue in USD Million) in 2022.
Russia Travel Vaccine Market is projected to grow at a CAGR of 11.28% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Russia Travel Vaccine Market, holding a largest market share of 136.50 USD Million in 2024
Russia Travel Vaccine Market Scope
Russia Travel Vaccine Market Segmentation & Scope
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Composition
- Mono Vaccines
- Combination Vaccines
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Frequently Asked Questions
The Russia Travel Vaccine Market is segmented based on Segmentation Category,Type,Disease,Composition,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration.
Russia Travel Vaccine Market was valued at USD 167.12(Revenue in USD Million) in 2022.
Russia Travel Vaccine Market is projected to grow at a CAGR of 11.28% during the forecast period of 2024 to 2032.
The estimated market value of the Russia Travel Vaccine Market for final year is USD 328.09 (USD Million).
Russia Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Russia Travel Vaccine Market is segmented based on Segmentation Category,Type,Disease,Composition,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration.
Russia Travel Vaccine Market was valued at USD 167.12(Revenue in USD Million) in 2022.
Russia Travel Vaccine Market is projected to grow at a CAGR of 11.28% during the forecast period of 2024 to 2032.
The estimated market value of the Russia Travel Vaccine Market for final year is USD 328.09 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.